Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
OTC Markets
ETFs
Canadian ETFs
US ETFs
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cipher Pharmaceuticals Inc
T.CPH
Alternate Symbol(s):
CPHRF
Healthcare
Drug Manufacturers - Specialty & Generic
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products...
, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(18)
•••
Daudau11
X
Post by
Daudau11
on May 26, 2023 2:58pm
SCD Interview on YouTube
Cipher Pharmaceuticals (TSX: CPH) Update with CEO Craig Mull - YouTube
(1)
•••
GJS471
X
Comment by
GJS471
on Mar 23, 2023 12:42pm
RE:RE:RE:CPH: Outperformer, Give Credit When Credit Is Due
I view the results as rather dismal. Cash to invest but no apparent plans and no reliable track record for doing so successfully. I have been an investor for a very long time and was
...more
(4)
•••
drewmumaw
X
Comment by
drewmumaw
on Mar 23, 2023 10:42am
RE:RE:CPH: Outperformer, Give Credit When Credit Is Due
I listened to the Q4 call. Revenue continues to dry up. MOB-015 and CF-101 are a minimum of 9 months and 12 months out, respectively. The only thing they have going for them is their big pile of cash
...more
(1)
•••
GJS471
X
Comment by
GJS471
on Mar 09, 2023 10:01am
RE:CPH: Outperformer, Give Credit When Credit Is Due
As we approach another quarterly earnings announcement, I just wanted to say that as a long time investor, my numbers are not yours. It has been what I classify as a "faith" investment
...more
(1)
•••
GJS471
X
Comment by
GJS471
on Feb 12, 2023 6:57am
RE:RE:No release date yet for Q4 and Full yr 2022 results
My apologies. You are very correct.
(1)
•••
GJS471
X
Comment by
GJS471
on Feb 09, 2023 2:04pm
RE:RE:No release date yet for Q4 and Full yr 2022 results
My apologies, you are absolutely correct. I thought there was a date announcing the release of the YE for CPH last year but all I see is the actual release date. I look forward to
...more
(30)
•••
Northforce13
X
Comment by
Northforce13
on Feb 08, 2023 4:16pm
RE:No release date yet for Q4 and Full yr 2022 results
last year Q4 results were out March 17th. We are Feb 8th.
(1)
•••
GJS471
X
Post by
GJS471
on Feb 07, 2023 2:02pm
No release date yet for Q4 and Full yr 2022 results
Given the history of earnings releases, it makes me wonder if they are hoping to include some additional news about the company and are holding back the date to release the results until they can make
...more
(28)
•••
stockfy
X
Post by
stockfy
on Nov 14, 2022 5:16am
CPH: Outperformer, Give Credit When Credit Is Due
I just want to give credit where credit is due. I bought CPH thanks to Value Digger, a veteran fund manager and author from Seeking Alpha and his research. I m one of his subscribers. Value Digger
...more
(28)
•••
stockfy
X
Comment by
stockfy
on Nov 14, 2022 5:12am
RE:RE:Very good Q
Where are all those bears who were posting ugly comments against CPH and its management team about one year ago when CPH was below CAD$1?
(0)
•••
Rsoleblocka
X
Comment by
Rsoleblocka
on Nov 12, 2022 12:52am
RE:Very good Q
Nice synopsis, I almost sold today at 3.70 but could not pull the trigger. As longs as they do not buy something for the sake of doing so I am still comfortable with this holding. Cheers
(30)
•••
Northforce13
X
Post by
Northforce13
on Nov 11, 2022 1:28pm
Very good Q
Solid results, big boost in profitability, though a big chunk of which is attributable to tax revaluation. 1) Great profitability 2) Tax revaluation was encouraging, indicates less
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 10, 2022 6:30pm
New Press Release - Cipher Pharmaceuticals Reports Strong Third Quarter Results, Highlighted by USD$1.09 in Cash Per Share
(All figures are presented in U.S. dollars)EPS increased YoY by $0.08 to $0.11 in the third quarter;Strengthened balance sheet and demonstrated continued positive cash flow, ending Q3 with $27.5 million in cash and Adjusted EBITDA2 increased 19% to $2.6 million; EBITDA2 increased 67% to $2.5...
read article.
(6)
•••
DrewJackson
X
Comment by
DrewJackson
on Nov 09, 2022 12:52pm
RE:Tomorrrow the wait will be over....
It's available on https://www.sedi.ca/ The System for Electronic Disclosure by Insiders (SEDI) is Canada's website for filing and viewing insider trades. SEDI is old and clunky, just
...more
(1)
•••
GJS471
X
Post by
GJS471
on Nov 09, 2022 8:59am
Tomorrrow the wait will be over....
Given the recent increase in the stock price, people are obviously thinking that they will report a solid quarter but it also looks like an expectation of M&A activity. Which was what people
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video
{{moreVideoText}}
Next Video >
Featured News Links
Milestone Agreement for Developing Radiology Drugs Announced
Exclusive Insights on the Precious Metals Industry and What to Expect in 2023 – Download free report
Green Metals Royalty Company: "The Perfect Junior Mining Investment?" - Read More Here